8SV9: ULK1 kinase domain with inhibitor MR-2088

Crystal structure of ULK1 kinase domain with inhibitor MR-2088. Determined by X-ray diffraction at 2.3 Å resolution. Released 27 Mar 2024.

Method
X-ray diffraction
Resolution
2.3 Å
Organism
Homo sapiens
Chains
2
Atoms
4,647
Mol. weight
65.74 kDa
Ligands
WXH
Released
27 Mar 2024

Explore 8SV9 in 3D Show helices and sheets RCSB PDB PDBe

Secondary structure: helices and β-sheets

8SV9 contains 24 α-helices and 28 β-strands across 2 chains. Residue ranges use author residue numbering, as in the PDB file, from PDBe. To see them in 3D, choose the Cartoon representation with Secondary structure coloring: helices, sheets and coils get different colors.

Chain A: 12 helices, 14 β-strands

ElementResiduesLengthSheet
β-strand9-1131
β-strand14-24111
β-strand29-3571
β-strand42-4761
α-helix50-523
α-helix53-6715
β-strand7512
β-strand78-8361
β-strand88-9361
β-strand9912
α-helix100-1078
α-helix112-13221
β-strand134-13523
α-helix141-1433
β-strand144-14742
β-strand160-16342
β-strand170-17123
β-strand17814
α-helix185-1873
α-helix190-1934
β-strand19814
α-helix201-21616
α-helix226-23510
α-helix249-25810
α-helix269-2735
α-helix276-2783
Chain B: 12 helices, 14 β-strands
ElementResiduesLengthSheet
β-strand9-1135
β-strand14-25125
β-strand28-3585
β-strand42-4765
α-helix53-6715
β-strand7516
β-strand78-8365
β-strand88-9365
β-strand9916
α-helix100-1078
α-helix112-13221
β-strand134-13527
α-helix141-1433
β-strand144-14746
α-helix156-1583
β-strand160-16346
β-strand170-17127
β-strand17818
α-helix185-1873
α-helix190-1934
β-strand19818
α-helix201-21616
α-helix226-23510
α-helix249-25810
α-helix269-2735
α-helix276-2783

Molecules and chains

MoleculeChainsTypeLengthOrganismUniProt
Serine/threonine-protein kinase ULK1A, Bprotein283Homo sapiensO75385 (AlphaFold model)
Sequence of entity 1 (A, B), FASTA
>8SV9_1 Serine/threonine-protein kinase ULK1 (chains A, B)
MEPGRGGTETVGKFEFSRKDLIGHGAFAVVFKGRHRAAHDLEVAVKCINKKNLAKSQTLL
GKEIKILKELKHENIVALYDFQEMANSVYLVMEYCNGGDLADYLHAMRTLSEDTIRLFLQ
QIAGAMRLLHSKGIIHRDLKPQNILLSNPAGRRANPNSIRVKIADFGFARYLQSNMMAAT
LCGSPMYMAPEVIMSQHYDGKADLWSIGTIVYQCLTGKAPFQASSPQDLRLFYEKNKTLV
PTIPRETSAPLRQLLLALLQRNHKDRMDFDEFFHHPFLDASPS

Ligands and cofactors

IDNameFormulaCopies
WXH(4P)-4-[(2P)-2-(1,2,5,6-tetrahydropyridin-3-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]-…C19 H17 F3 N4 O S2

Water and common crystallization additives (EDO, SO4) are not listed.

Primary citation

Development of potent and selective ULK1/2 inhibitors based on 7-azaindole scaffold with favorable in vivo properties. Morozova, A., Chan, S.C., Bayle, S. et al. Eur J Med Chem (2024) 266:116101-116101. DOI 10.1016/j.ejmech.2023.116101 · PubMed

Other PDB entries of the same protein (UniProt O75385 (AlphaFold model), which also has an AlphaFold model), best resolution first:

Browse structure collections

About this viewer

MolViewer shows 8SV9 directly in your browser with nothing to install. Switch between cartoon, ball-and-stick, spacefill and surface views, color by chain, secondary structure or B-factor, measure distances, angles and dihedrals, and share or embed the view.